ID
21925
Beschreibung
The present pharmacokinetic study is designed to assess the pharmacokinetics of RSG XR as monotherapy in patients with mild Alzheimer's disease (AD) as such information will not be obtained from the current phase III trials . The study aims to enroll fourteen patients (seven of each APOE genotype). Each patient will receive a single oral dose of 4mg of RSG XR in the morning under fasted conditions and PK samples will be taken up to 36h. GSK Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00688207?term=NCT00688207&rank=1
Link
https://clinicaltrials.gov/ct2/show/NCT00688207?term=NCT00688207&rank=1
Stichworte
Versionen (2)
- 08.05.17 08.05.17 -
- 20.05.17 20.05.17 -
Hochgeladen am
8. Mai 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Concomitant Medications Mild Alzheimer's Disease to Assess the of Extended Release Formulation of Rosiglitazone NCT00688207 / GSK-AVA109941
Concomitant Medications Mild Alzheimer's Disease to Assess the of Extended Release Formulation of Rosiglitazone NCT00688207 / GSK-AVA109941
Beschreibung
Medication
Alias
- UMLS CUI-1
- C0013227 (Pharmaceutical Preparations)
- SNOMED
- 763158003
- LOINC
- LP100609-9
Beschreibung
Drug name
Datentyp
text
Alias
- UMLS CUI [1]
- C0013227 (Pharmaceutical Preparations)
- SNOMED
- 763158003
- LOINC
- LP100609-9
Beschreibung
Unit Dose
Datentyp
float
Alias
- UMLS CUI [1]
- C0869039 (Unit dose)
- SNOMED
- 408102007
Beschreibung
Units
Datentyp
text
Alias
- UMLS CUI [1]
- C1519795 (Unit of Measure)
- SNOMED
- 767524001
Beschreibung
Frequency
Datentyp
text
Alias
- UMLS CUI [1]
- C3476109 (Medication frequency)
- LOINC
- LP149758-7
Beschreibung
Route
Datentyp
text
Alias
- UMLS CUI [1]
- C0013153 (Drug Administration Routes)
- SNOMED
- 410675002
- LOINC
- LP40261-7
Beschreibung
Reason for Medication
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0392360 (Indication of (contextual qualifier))
- SNOMED
- 230165009
- LOINC
- MTHU008319
- UMLS CUI [1,2]
- C0013227 (Pharmaceutical Preparations)
- SNOMED
- 763158003
- LOINC
- LP100609-9
Beschreibung
Start Date
Datentyp
date
Alias
- UMLS CUI [1]
- C0808070 (Start Date)
Beschreibung
Start time
Datentyp
time
Maßeinheiten
- hh:min
Alias
- UMLS CUI [1]
- C1301880 (Start time)
- SNOMED
- 398201009
- LOINC
- LP102339-1
Beschreibung
Taken Prior to Study
Datentyp
boolean
Alias
- UMLS CUI [1]
- C2826667 (Concomitant Medication Previous Occurrence)
Beschreibung
Stop Date
Datentyp
date
Alias
- UMLS CUI [1]
- C0806020 (End date)
- SNOMED
- 454551000124105
- LOINC
- MTHU008302
Beschreibung
Stop Time
Datentyp
time
Alias
- UMLS CUI [1]
- C1522314 (End Time)
- SNOMED
- 397898000
Beschreibung
Ongoing Medication
Datentyp
boolean
Alias
- UMLS CUI [1]
- C2826666 (Concomitant Medication Ongoing)
Ähnliche Modelle
Concomitant Medications Mild Alzheimer's Disease to Assess the of Extended Release Formulation of Rosiglitazone NCT00688207 / GSK-AVA109941
C0013227 (UMLS CUI [1,2])
Keine Kommentare